Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumour necrosis factor therapy in rheumatoid arthritis (Q37245188)

From Wikidata

Jump to navigation Jump to search

scientific article published on 22 August 2008

Language	Label	Description	Also known as
English	Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumour necrosis factor therapy in rheumatoid arthritis	scientific article published on 22 August 2008

Statements

scholarly article

1 reference

Europe PubMed Central

19 August 2017

Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumour necrosis factor therapy in rheumatoid arthritis (English)

1 reference

Europe PubMed Central

19 August 2017

0 references

0 references

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

John J. P. Kastelein

6

object named as

J J P Kastelein

1 reference

Europe PubMed Central

19 August 2017

author name string

C A Wijbrandts

1

1 reference

Europe PubMed Central

19 August 2017

S I van Leuven

2

1 reference

Europe PubMed Central

19 August 2017

H D Boom

3

1 reference

Europe PubMed Central

19 August 2017

D M Gerlag

4

1 reference

Europe PubMed Central

19 August 2017

E G S Stroes

5

1 reference

Europe PubMed Central

19 August 2017

P P Tak

7

1 reference

Europe PubMed Central

19 August 2017

language of work or name

0 references

publication date

22 August 2008

1 reference

Europe PubMed Central

19 August 2017

Annals of the Rheumatic Diseases

1 reference

Europe PubMed Central

19 August 2017

68

1 reference

Europe PubMed Central

19 August 2017

1316-1321

1 reference

Europe PubMed Central

19 August 2017

8

1 reference

Europe PubMed Central

19 August 2017

Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2703704

14 September 2017

Systemic inflammation as a risk factor for atherothrombosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2703704

14 September 2017

Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2703704

14 September 2017

MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2703704

14 September 2017

Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2703704

14 September 2017

Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2703704

14 September 2017

MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2703704

14 September 2017

Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2703704

14 September 2017

Inflammation in atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2703704

14 September 2017

Lipoprotein (a) as a predictor of coronary heart disease: the PRIME Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2703704

14 September 2017

The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2703704

14 September 2017

Migration inhibitory factor up-regulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 via Src, PI3 kinase, and NFkappaB

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2703704

14 September 2017

Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2703704

26 June 2018

Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2703704

26 June 2018

Anti-TNF therapy and plasma HDL cholesterol concentration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2703704

3 September 2018

Reduced leukocyte-endothelial cell interactions in the inflamed microcirculation of macrophage migration inhibitory factor-deficient mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2703704

3 September 2018

Macrophage migration inhibitory factor and the risk of myocardial infarction or death due to coronary artery disease in adults without prior myocardial infarction or stroke: the EPIC-Norfolk Prospective Population study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2703704

3 September 2018

Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2703704

3 September 2018

Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2703704

3 September 2018

Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2703704

3 September 2018

Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2703704

3 September 2018

Macrophage migration inhibitory factor (MIF) and risk for coronary heart disease: Results from the MONICA/KORA Augsburg case-cohort study, 1984–2002

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2703704

4 December 2018

Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2703704

4 December 2018

Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18723565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlations

1 reference

https://pubmed.ncbi.nlm.nih.gov/18723565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor necrosis factor alpha blockade reduces the synovial cell infiltrate early after initiation of treatment, but apparently not by induction of apoptosis in synovial tissue

1 reference

https://pubmed.ncbi.nlm.nih.gov/18723565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stabilization of Atherosclerotic Plaques by Blockade of Macrophage Migration Inhibitory Factor After Vascular Injury in Apolipoprotein E–Deficient Mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/18723565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18723565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18723565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High expression of macrophage migration inhibitory factor in the synovial tissues of rheumatoid joints

1 reference

https://pubmed.ncbi.nlm.nih.gov/18723565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lipoprotein(a)-cholesterol and coronary heart disease in the Framingham Heart Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18723565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids

1 reference

https://pubmed.ncbi.nlm.nih.gov/18723565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MIF production by dendritic cells is differentially regulated by Toll-like receptors and increased during rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18723565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic proinflammatory effects of the antiviral cytokine interferon-alpha and Toll-like receptor 4 ligands in the atherosclerotic plaque

1 reference

https://pubmed.ncbi.nlm.nih.gov/18723565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic anti-tumor necrosis factor α therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor α synthesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18723565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/ARD.2007.086728

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37245188&oldid=1697393821"